Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Evaluation of the Effect of Androgen Ablation on Bone Resorption in Prostate Cancer Patients

NCT00003903 is registered in ClinicalTrials.gov with University of Rochester as lead sponsor.

NCT NCT00003903
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003903 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Evaluation of the Effect of Androgen Ablation on Bone Resorption in Prostate Cancer Patients
Lead sponsor
University of Rochester
Phase
Not applicable
Overall status
Completed
Start date
July 31, 1999
Completion date
August 31, 2007
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

osteoporosis, prostate cancer